首页> 外文期刊>Reproductive and Developmental Medicine >Diagnostic accuracy of colposcopically directed biopsy and loop electrosurgical excision procedure for cervical lesions
【24h】

Diagnostic accuracy of colposcopically directed biopsy and loop electrosurgical excision procedure for cervical lesions

机译:阴道镜下活检和环行电外科切除术对宫颈病变的诊断准确性

获取原文
       

摘要

Objective: The aim of this study is to evaluate the diagnostic accuracy of colposcopically directed biopsy (CDB) and loop electrosurgical excision procedure (LEEP) for cervical lesions and assess their ability to detect glandular involvement. Methods: This retrospective study reviewed 4689 cervical lesions that were tested by CDB and LEEP at a tertiary hospital. The sensitivity, specificity, and predictive value of CDB and LEEP and the ratio of glandular involvement detected by these two methods were analyzed. Results: CDB and LEEP had sensitivities of 95.4% and 80.0%, respectively, for diagnosing high-grade intraepithelial or more severe lesions (HSIL+) (P = 0.000) and 31.8% and 87.9%, respectively, for diagnosing adenocarcinoma in situ or more severe lesions (AIS+) (P = 0.001). CDB and LEEP had sensitivities of 18.1% and 90.2%, respectively, for diagnosing invasive squamous cell carcinoma (P = 0.000) and 5.9% and 98.0%, respectively, for diagnosing invasive adenocarcinoma (P = 0.000). The negative predictive values of CDB and LEEP for diagnosing HSIL+ were 88.6% and 64.4%, respectively (P = 0.000). The ratios of glandular involvement were 0.2% (CDB) and 2.4% (LEEP) in low-grade intraepithelial lesions (LSILs) and 8.9% (CDB) and 59.0% (LEEP) (P = 0.000) in HSIL+. Conclusions: LEEP is superior to CDB for diagnosing AIS and detecting early invasive cancer. It should be offered as an additional investigation to all patients with AIS, HSIL, or LSIL with glandular involvement on CDB.
机译:目的:本研究旨在评估阴道镜下活检(CDB)和环行电外科切除术(LEEP)对宫颈病变的诊断准确性,并评估其检测腺体受累的能力。方法:这项回顾性研究回顾了由一家三级医院的CDB和LEEP测试的4689例宫颈病变。分析了这两种方法对CDB和LEEP的敏感性,特异性和预测价值以及腺体受累的比率。结果:CDB和LEEP诊断高级别上皮内或更严重病变(HSIL +)的敏感性分别为95.4%和80.0%(P = 0.000),原位诊断腺癌或以上的敏感性分别为31.8%和87.9%。严重病变(AIS +)(P = 0.001)。 CDB和LEEP诊断浸润性鳞状细胞癌的敏感性分别为18.1%和90.2%(P = 0.000),诊断浸润性腺癌的敏感性分别为5.9%和98.0%(P = 0.000)。 CDB和LEEP对HSIL +诊断的阴性预测值分别为88.6%和64.4%(P = 0.000)。在低度上皮内病变(LSIL)中,腺体受累的比例为0.2%(CDB)和2.4%(LEEP),在HSIL +中,腺体受累的比例为8.9%(CDB)和59.0%(LEEP)(P = 0.000)。结论:LEEP在诊断AIS和检测早期浸润性癌症方面优于CDB。对于所有患有CDB的AIS,HSIL或LSIL的患者,应将其作为补充检查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号